including the ability to travel to the infected area kill infected organisms and increase the number of white blood cells when needed boost immunity The world's leading experts in immunology and microbiology. Two clinical studies were performed using an advanced form of quercetin phytosome. in the early stages of acute respiratory viral infections.

In the first study, 152 people with mild to moderate upper respiratory tract infections. received standard care or standard care and 500 mg quercetin phytosome Twice a day for 30 days, the results are very positive. If in the standard treatment group, 28.9 percent of the patients had to be hospitalized. Then in the group receiving quercetin phytosomes

อ่านเพิ่มเติม โรงเรียนวัดมะปรางงาม
นานาสาระ เควอซิทิน